Drug delivery device with compressible drug reservoir

Information

  • Patent Grant
  • 10046109
  • Patent Number
    10,046,109
  • Date Filed
    Tuesday, August 10, 2010
    13 years ago
  • Date Issued
    Tuesday, August 14, 2018
    5 years ago
Abstract
A drug delivery device (50) is provided comprising a drug reservoir (10) and a piston (11). The drug reservoir (10) is provided for comprising a drug and comprises a flexible wall (22) and a dispensing hole (15) for dispensing the drug into an environment of the drug de delivery device (50). The piston (11) is provide for pressing against the flexible wall (22) to compress the drug reservoir (10) for pushing an amount of the drug through the dispensing hole (15). An adhesion interface (51) between a surface of the piston (11) and the flexible wall (22) prevents sliding between the surface of the piston (11) and the flexible wall (22).
Description
FIELD OF THE INVENTION

This invention relates to a drug delivery device, comprising a piston and a drug reservoir for comprising a drug and a piston. The drug reservoir comprises a flexible wall, and a dispensing hole for dispensing the drug into an environment of the drug delivery device. The piston is arranged for pressing against the flexible wall to compress the drug reservoir for pushing an amount of the drug through the dispensing hole.


BACKGROUND OF THE INVENTION

Such a drug delivery device may comprise a small sized electrical motor, e.g. stepper motor, of which the action is controlled by an on-board microprocessor. The stepper motor moves the piston forward against the wall, e.g. pushed by a screw rod mechanism. The piston is moved in a controlled way as far as speed and stroke are considered. The piston pushes the flexible wall into the drug reservoir. As a result, the volume of the drug reservoir decreases and the pressure inside the drug reservoir increases. The increasing pressure causes an amount of the drug to be pushed out of the dispensing hole. While the piston pushes the flexible wall into the drug reservoir, it takes a shape that corresponds to minimum surface energy. Such shapes usually are irregular, resulting in a smaller usable drug reservoir volume and a higher resistance for the piston to move forward. When the drug reservoir becomes emptier, the flexible wall starts to fold until the piston can no longer overcome resistance from the folds and the drug viscosity and stops dispensing. When the piston stops dispensing, drugs stay behind in the folds. Consequently, it is not possible to fully empty the drug reservoir. Additionally, there is a problem of the piston sliding along the folded flexible wall surface without causing any drug to be pushed out of the dispensing hole because the piston mechanism cannot be effective.


OBJECT OF THE INVENTION

It is an object of the invention to provide a drug delivery device as described above, wherein the drug reservoir can be emptied more reliably.


SUMMARY OF THE INVENTION

According to a first aspect of the invention, this object is achieved by providing a drug delivery device, comprising a drug reservoir, a piston and an adhesion interface. The drug reservoir comprises a flexible wall and a dispensing hole for dispensing the drug into an environment of the drug delivery device. The piston is arranged for pressing against the flexible wall to compress the drug reservoir for pushing an amount of the drug through the dispensing hole. The adhesion interface is situated between a surface of the piston and the flexible wall for preventing sliding between the surface of the piston and the flexible wall.


The adhesion interface keeps the flexible wall surface conformed to the piston surface and prevents both surfaces from slipping between each other. With every step of the piston into the flexible wall and in the direction of the delivery hole, a greater part of its surface gets covered by and adheres to the flexible wall surface. The flexible wall surface does not fold, but is slid around the piston surface.


The adhesion interface may, e.g., be a sticky coating on the piston surface and/or on the flexible wall. Alternatively, a magnetic coating is used on at least one of the two surfaces for providing the required adhesion.


In a preferred embodiment, the flexible wall comprises at least one non-flexible part located at the adhesion interface. An advantage of a non-flexible part is that it cannot be folded or wrinkled. When the piston pushes against a non-flexible part, its shape does not change. The flexible parts of the flexible wall meanwhile ensure that the flexible wall as a whole is still deformable and can be used for compressing the drug reservoir.


In a flexible wall with only one or a few non-flexible parts, the surface of the non-flexible parts preferably follows the contours of the piston surface at the contact area of both surfaces. This ensures an optimal distribution of the pressure exerted by the piston upon the flexible wall and further facilitates the emptying of the reservoir. In addition, the preformed flexible wall makes it easier to fill the reservoir to the right dose without the piston already placed against the flexible wall.


These and other aspects of the invention are apparent from and will be elucidated with reference to the embodiments described hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1 shows a drug delivery device according to the invention,



FIG. 2 shows a piston and an uncompressed drug reservoir,



FIGS. 3 and 4 show partially compressed drug reservoirs in a drug delivery device according to the prior art,



FIG. 5 shows a partly compressed drug reservoir in a drug delivery device according to the invention,



FIG. 6 shows a partly compressed drug reservoir with a non-flexible part in the flexible wall, and



FIG. 7 shows a partly compressed drug reservoir with multiple rigid parts in the flexible wall.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows a drug delivery device 50 according to the invention. The drug delivery device 50 is a swallowable capsule comprising a drug to be released somewhere along the gastro-intestinal tract of a patient and an actuation mechanism 11, 12 for controlling the amount of drugs to be released and the moment of said release. It is to be noted that the current invention may also be used with implantable drug delivery devices. The drug to be released is stored in a compressible medicine reservoir 10. The drug may, e.g., be stored as dry powder, dissolved in water or as a gel or liquid.


The actuation mechanism 11, 12 comprises a piston 11 and a small sized electrical motor, e.g. a stepper motor 12, for pushing the piston by means of a screw rod mechanism towards the drug reservoir 10. Instead of a stepper motor 12, different driving means may be used for driving the piston 12. The driving of the piston 11 may, e.g., be realized using (electro-)magnetic forces or a swelling agent. When the piston 11 is pressed against the medicine reservoir 10, the medicine reservoir is compressed and the pressure inside the medicine reservoir 10 increases. As a result of the increasing pressure, the drug is pushed out of the drug delivery device 50 through a dispensing hole 15. The drug release may, e.g., be triggered by an internal clock, sensor values from a pH-sensor or trigger signals from an electrical or chemical detector element. If the drug delivery device 50 comprises means for wireless communication, the drug delivery may be externally triggered. The operations of all electronic functions of the device 50 are controlled by a microprocessor 17 and powered by a battery 16.



FIG. 2 shows a piston 11 and an uncompressed drug reservoir 10. The drug reservoir 10 comprises a rigid dome shaped cap 21 and a flexible wall 22. The drug reservoir 10 shown in FIG. 2 is an example of a drug reservoir for which the current invention would be advantageous. The invention will however also improve the emptying of other drug reservoirs 10 with a flexible wall. For example, the complete drug reservoir 10 may be flexible or the dome shaped cap 21 and/or the flexible wall 22 may have different shapes than shown in the Figure. When the piston 11 is driven into the flexible wall 22 of the drug reservoir 10, the reservoir volume is compressed and an amount of the drug is released through the delivery hole 15.



FIGS. 3 and 4 show partially compressed drug reservoirs 10 in a drug delivery device according to the prior art. In both Figures the flexible parts 22 of the drug reservoirs are compressed, while the dome shaped cap 21 keeps its shape. In FIG. 3, the flexible wall 22 has been compressed to a lesser extent than in FIG. 4. In FIG. 3 it is already visible that, due to uneven surface tension, the flexible wall shape does not conform to the piston 11 profile. This will result in an increased resistance for the piston 11 and drugs staying behind in folds of the flexible wall 22. As can be seen in FIG. 4, uneven surface tension and drug viscosity may cause the flexible wall 22 of a half full drug reservoir 10 to form multiple folds. Such folds increase the resistance to the piston 11 and may completely stop the dispensing of the drugs. In addition, the folds reduce the contact area between the flexible wall 22 and the piston 11, leading to slip between both and the piston not moving along its central axis 41 because the screw rod mechanism does not function properly.



FIG. 5 shows a partly compressed drug reservoir 10 in a drug delivery device 50 according to the invention. In this embodiment, the problems of the prior art are solved by the introduction of an adhesion interface 51 in between the piston 11 and the flexible wall 22. The adhesion interface 51 keeps the flexible wall 22 conformed to the piston 11 surface and thus prevents slipping between both surfaces and folding of the flexible wall 22. The adhesion 51 may cover the complete piston 11 surface and/or the complete surface of the flexible wall 22. In a preferred embodiment the adhesion surface 51 only covers the parts of those surfaces which are designed to make contact with each other. Alternatively, the adhesion surface 51 may cover only part of the expected contact area.


The adhesion surface 51 may be a sticky surface applied to the piston 11 and/or flexible wall 22 surface. Alternatively, a magnetic coating may cover one of the surfaces, while the other surface is either magnetic or magnetizable. Another option is to use electrostatic interaction using an electrostatically charged polymer. A skilled person will be able to come up with many other possible ways of providing a suitable adhesion surface 51. The adhesion surface 51 used is preferably such that the drug reservoir 10 can still be removed from the adhered piston 11 surface for enabling refilling of the drug reservoir 10 without damaging the piston 11 or the drug reservoir. It is preferable that also the adhesion layer 51 keeps intact when the drug reservoir 10 and the piston 11 are separated. Alternatively, the drug reservoir 10 and/or the adhesion layer 51 are replaced when preparing the drug delivery device 50 for a second use.


Such an adhesion layer 51, which makes it possible to separate the surfaces without damaging the piston 11 or the reservoir 10, also enables a further option. When the reservoir 10 is completely or partly compressed and the piston 11 movement is reversed, the pressure inside the reservoir 10 will drop and body fluid will be sucked into the reservoir 10.



FIG. 6 shows a partly compressed drug reservoir 10 with a non-flexible part 61 in the flexible wall 22. The shape of the non-flexible part 61 follows the contours of the opposing piston 11 surface. In this embodiment this means that the non-flexible part 61 is dome shaped. An advantage of this non-flexible part 61 is that it cannot be folded or wrinkled. When the piston pushes against the non-flexible part 61, its shape does not change. The flexible parts of the flexible wall 22 meanwhile ensure that the flexible wall 22 as a whole is still deformable and that drug reservoir 10 is still compressible.


The non-flexible part 61 ensures an optimal distribution of the pressure exerted by the piston 11 upon the flexible wall 22 and further facilitates the emptying of the reservoir 10. In addition, the preformed flexible wall 22 makes it easier to fill the reservoir to the right dose without the piston 11 already placed against the flexible wall 22. If a fully flexible drug reservoir 10 would be filled to the rim, the viscosity of the drug may result in too much resistance for the piston to start moving.



FIG. 7 shows a partly compressed drug reservoir 10 with multiple rigid parts 71 in the flexible wall. The rigid parts 71 are alternated with flexible parts 72 for providing the required flexibility to the flexible wall 22.


It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design many alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. Use of the verb “comprise” and its conjugations does not exclude the presence of elements or steps other than those stated in a claim. The article “a” or “an” preceding an element does not exclude the presence of a plurality of such elements. The invention may be implemented by means of hardware comprising several distinct elements, and by means of a suitably programmed computer. In the device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage.

Claims
  • 1. A capsule, comprising: a reservoir defining a volume for containing a substance, the reservoir comprising a flexible wall and a hole providing a fluid passageway between the reservoir and an environment;a piston disposed on a side of the flexible wall opposite the volume, the piston comprising an outer surface proximate a side of the flexible wall opposite the volume;an adhesion interface adhering the outer surface of the piston to the side of the flexible wall opposite the volume to maintain conformity of the flexible wall to the piston, andwherein at least one of the following holds: (1) the adhesion surface comprises a sticky coating on the surface of the piston, the sticky coating comprising a silicon based resin, (2) the adhesion surface comprises a magnetic coating, or (3) the adhesion surface comprises an electrostatically charged polymer.
  • 2. The capsule of claim 1, wherein the adhesion interface comprises a sticky coating on the surface of the piston and wherein the sticky coating comprises a silicon based resin.
  • 3. The capsule of claim 1, wherein the adhesion interface comprises a sticky coating on the flexible wall.
  • 4. The capsule of claim 1, wherein the adhesion surface comprises a magnetic coating.
  • 5. The capsule of claim 1, wherein the adhesion surface comprises an electrostatically charged polymer.
  • 6. The capsule of claim 1, wherein the flexible wall comprises at least one non-flexible part located at the adhesion interface.
  • 7. The capsule of claim 1, wherein the drug delivery device is a swallowable drug delivery device.
  • 8. The capsule of claim 1, wherein the drug delivery device is an implantable drug delivery device.
  • 9. The capsule of claim 1, further comprising an actuator for moving the piston relative to the hole in at least one of a first direction to compress the reservoir or a second direction to expand the reservoir.
  • 10. The capsule of claim 1, wherein the reservoir contains a substance to be dispensed, the piston being configured be pressed against the flexible wall to compress the reservoir and push an amount of the substance to be dispensed through the hole.
  • 11. The capsule of claim 1, wherein the piston is configured to be moved away from the hole and the adhesion interface retains the flexible wall against the piston to expand the reservoir, the expansion causing contents from the environment to enter the reservoir via the hole.
  • 12. A capsule comprising: a housing comprising a rigid, dome-shaped cap;an opening through the rigid, dome-shaped cap;a reservoir in the housing defined at least in part by a flexible wall spaced from the opening and an internal surface of the rigid, dome-shaped cap;a piston disposed in the housing on a first side of the flexible wall opposite the opening and arranged to contact the first side of the flexible wall, the flexible wall separating the piston from contents in the reservoir, the piston being movable relative to the opening, and a portion of the piston having a domed shape; andan adhesion interface adhering a portion of the first side of the flexible wall to a portion of the piston, the adhesion interface maintaining conformity of the flexible wall to the portion of the piston having the domed shape.
  • 13. The capsule of claim 12, wherein the flexible wall comprises at least one non-flexible p art and the non-flexible part is adhered to the piston at the adhesion surface.
  • 14. The capsule of claim 12, wherein the adhesion surface comprises a sticky coating on the portion of the piston or on the surface of the flexible wall.
  • 15. The capsule of claim 12, wherein the adhesion surface comprises a magnetic interface.
  • 16. The capsule of claim 12, wherein the adhesion surface comprises an electrostatic charge.
  • 17. The capsule of claim 12, wherein the reservoir is removable from the housing for refilling or replacement and the adhesion surface is remains intact on the piston when the reservoir is removed for refilling or replacement.
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/IB2010/053610 8/10/2010 WO 00 2/7/2013
Publishing Document Publishing Date Country Kind
WO2011/018753 2/17/2011 WO A
US Referenced Citations (42)
Number Name Date Kind
4102998 Gutnick Jul 1978 A
4236516 Nilson Dec 1980 A
4457752 Vadasz Jul 1984 A
4564363 Bagnall et al. Jan 1986 A
4572403 Benaroya Feb 1986 A
4814180 Eckenhoff et al. Mar 1989 A
5071040 Laptewicz, Jr. Dec 1991 A
5170801 Casper et al. Dec 1992 A
5279607 Schentag et al. Jan 1994 A
5318557 Gross Jun 1994 A
5423779 Yeh Jun 1995 A
5567592 Benet et al. Oct 1996 A
5728396 Peery et al. Mar 1998 A
5853386 Davis et al. Dec 1998 A
6053899 Slanda et al. Apr 2000 A
6182941 Scheurenbrand et al. Feb 2001 B1
6423779 Sue et al. Jul 2002 B2
6485471 Zivitz et al. Nov 2002 B1
6632216 Houzego et al. Oct 2003 B2
6699214 Gellman Mar 2004 B2
6776165 Jin Aug 2004 B2
6800060 Marshall Oct 2004 B2
6803373 Schellens Oct 2004 B2
6929636 von Alten Aug 2005 B1
7014640 Kemppainen et al. Mar 2006 B2
7030132 Schellens et al. Apr 2006 B2
8021357 Tanaka et al. Sep 2011 B2
8100889 Kawano et al. Jan 2012 B2
8308681 Slocum et al. Nov 2012 B2
20020072735 Kupperblatt et al. Jun 2002 A1
20030020810 Takizawa et al. Jan 2003 A1
20030213495 Fujita et al. Nov 2003 A1
20040242962 Uchiyama Dec 2004 A1
20040267240 Gross et al. Dec 2004 A1
20040267241 Russell Dec 2004 A1
20050147559 von Alten Jul 2005 A1
20050222537 Dinsmoor et al. Oct 2005 A1
20060145876 Kimura et al. Jul 2006 A1
20060155174 Glukhovsky et al. Jul 2006 A1
20070138027 Dinsmoor et al. Jun 2007 A1
20070213659 Trovato et al. Sep 2007 A1
20100280464 De Graaff et al. Nov 2010 A1
Foreign Referenced Citations (23)
Number Date Country
1958090 May 2007 CN
3339323 May 1985 DE
2794654 Dec 2000 FR
2001526939 Dec 2001 JP
2002532162 Oct 2002 JP
2003520108 Jul 2003 JP
2005511184 Apr 2005 JP
2005536307 Dec 2005 JP
WO03008637 Jan 2003 WO
WO03068061 Aug 2003 WO
WO2005025647 Mar 2005 WO
WO2005038049 Apr 2005 WO
WO2006021932 Mar 2006 WO
WO2006025013 Mar 2006 WO
WO2006044049 Apr 2006 WO
WO2006056944 Jun 2006 WO
WO2006077527 Jul 2006 WO
WO2006077529 Jul 2006 WO
WO2008029372 Mar 2008 WO
WO2008038199 Apr 2008 WO
WO2008062335 May 2008 WO
WO 2008062335 May 2008 WO
WO2010086681 Aug 2010 WO
Non-Patent Literature Citations (20)
Entry
The Chinese Office Action dated Sep. 6, 2013 for Chinese patent application No. 201080040663.6, a counterpart foreign application of U.S. Appl. No. 13/390,111, 4 pages.
The Chinese Office Action dated Jan. 15, 2013 for Chinese patent application No. 201080015953.5, a counterpart foreign application of U.S. Appl. No. 13/262,841, 17 pages.
The Chinese Office Action dated Jan. 21, 2013 for Chinese patent application No. 201080040663.6, a counterpart foreign application of U.S. Appl. No. 13/390,111, 8 pages.
The Chinese Office Action dated Mar. 14, 2013 for Chinese patent application No. 200980112018.8, a counterpart foreign application of U.S. Appl. No. 12/933,891, 12 pages.
The Chinese Office Action dated May 13, 2013 for Chinese patent application No. 201080015284.1, a counterpart foreign application of U.S. Appl. No. 13/262,861, 11 pages.
The Chinese Office Action dated Aug. 5, 2013 for Chinese patent application No. 201080015953.5, a counterpart foreign application of U.S. Appl. No. 13/262,841, 7 pages.
The European Office Action dated Jul. 25, 2013 for European patent application No. 10779040.4, a counterpart foreign application of U.S. Appl. No. 13/498,835, 4 pages.
Evans, et al., “Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects”, GUT, vol. 29, 1988, pp. 1035-1041.
Hindmarsh et al., “Height Monitoring as a diagnostic test”, at www.archdischild.com, Arch Dis Child, 2004, 2 pages.
The Japanese Office Action dated Apr. 16, 2013 for Japanese Patent Applicaiton No. 2011-514179, a counterpart foreign application of U.S. Appl. No. 12/992,305, 9 pages.
The Japanese Office Action dated Apr. 23, 2013 for Japanese patent application No. 2012-524322, a counterpart foreign application of U.S. Appl. No. 13/390,111, 6 pages.
The Japanese Office Action dated Apr. 30, 2013 for Japanese patent application No. 2010-546431, a counterpart foreign application of U.S. Appl. No. 12/867,888, 4 pages.
The Japanese Office Action dated Jun. 25, 2013 for Japanese patent application No. 2012531527, a counterpart foreign application of U.S. Appl. No. 13/498,835, 8 pages.
Kompella, et al., “Delivery System for Penetration Enhancement of Peptide and Protein Drugs: Design Considerations”, Advanced Drug Delivery Reviews, vol. 46, 2001, pp. 211-245.
Office action for U.S. Appl. No. 12/992,305, dated Jul. 16, 2013, Zou et al., “Device for Delivery of Powder Like Medication in a Humid Environment”, 14 pages.
Non-Final Office Action for U.S. Appl. No. 11/720,242, dated Jul. 3, 2013, Gerardus Rudolph Langereis et al., “Electronically Controlled Pill and System Having at Least One Sensor for Delivering at Least One Medicament”, 22 pages.
Office action for U.S. Appl. No. 13/262,861, dated Aug. 2, 2013, Shimizu et al., “Valveless Drug Delivery Device”, 8 pages.
Office action for U.S. Appl. No. 12/867,888, dated Sep. 11, 2013,Shimizu, “Administration of Drugs to a Patient”, 11 pages.
Paine, et al., “Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism”, The Journal of Pharmacology and Experimental Therapeutics, vol. 283, No. 3, 1997, pp. 1552-1562.
Siccardi, et al., “Regulation of Intestinal Epithelial Function: A Link Between Opportunities for Macromolecular Drug Delivery and Inflammatory Bowel Disease”, Advanced Drug Delivery Reviews, vol. 57, 2005, pp. 219-235.
Related Publications (1)
Number Date Country
20130204233 A1 Aug 2013 US
Provisional Applications (1)
Number Date Country
61233187 Aug 2009 US